Abstract:Background: The metabolism study of active components for traditional Chinese medicine (TCM) in target organs is conducive to clarify the authentic active ingredients. Notoginsenoside R1 (NG-R1), one of the bioactive components of Panax notoginsenoside (PNS), is commonly acknowledged as the characteristic marker of PNS. However, the metabolism of NG-R1 in target organs has not been clarified yet due to the lack of robust technique and approach. Purpose: The present study aimed to develop a reliable and efficient strategy and technology for revealing the qualitative and quantitative metabolism of active components of TCMs in target organs, and to clarify the biotransformation of NG-R1 in liver-brain-intestinal axis. Methods: The metabolic transformation of NG-R1 in the brain gut axis was investigated in the in vitro incubation system of fresh rat brain, liver homogenate, and intestinal flora. To quickly lock the target metabolites, we set the mass defect filter (MDF) in different ranges to screen metabolites with different molecular weight (MW). This strategy was defined as multi-stage MDF (mMDF). In addition, we performed relative quantitative analysis on all metabolites according to the peak area acquired by LC-IT-TOF/MS to overcome the challenge that metabolites are difficult to be quantified due to the lack of standards. Results: When MDF was set at 0.50 to 0.65 to screen metabolites with MW of 900 to 1200 Da, 6 novel metabolites were quickly found, and then identified as glucuronic acid binding, oxidation, dehydrogenation, methylation and hydrogenation products according to their LC and MS characteristics. When setting MDF at 0.42 - 0.52, 6 metabolites with MW of 600 to 900 Da were effectively screened and identified as Rg1, NG-R2, Rh1, Rg1+CH2+2H and Rg1+CH2. To screen the metabolites with MW of 300 to 600 Da, MDF was set at 0.25 - 0.42, and 4 novel metabolites were screened rapidly. The results of quantitative metabolism suggested that intestinal flora was the main metabolic site of NG-R1 in rat, and more than 60% of NG-R1 was converted to Rg1 by deglycosylation in the intestinal flora. Conclusion: The mMDF strategy can significantly improve the research efficiency of qualitative metabolism of saponins. Although NG-R1 could be transformed into a variety of metabolites in rat liver and brain homogenate, it still existed mainly in prototype form. In the rat flora, NG-R1 mainly existed in the form of deglycosylated metabolite Rg1.

Combination of UHPLC/Q-TOF-MS, NMR Spectroscopy, and ECD Calculation for Screening and Identification of Reactive Metabolites of Gentiopicroside in Humans

Identification of bio-active metabolites of gentiopicroside by UPLC/Q-TOF MS and NMR.

Identification of Constituents in Gui-Zhi-Jia-Ge-Gen-Tang by LC-IT-MS Combined with LC-Q-TOF-MS and Elucidation of Their Metabolic Networks in Rat Plasma after Oral Administration.

Simultaneous Determination of Gentiopicroside and Its Two Active Metabolites in Rat Plasma by Lc-Ms/Ms and Its Application in Pharmacokinetic Studies

Identification of Metabolites of Geniposide in Rat Urine Using Ultra-Performance Liquid Chromatography Combined with Electrospray Ionization Quadrupole Time-of-flight Tandem Mass Spectrometry.

Metabolic Transformation of Gentiopicrin, a Liver Protective Active Ingredient, Based on Intestinal Bacteria

Screening and Identification of Three Typical Phenylethanoid Glycosides Metabolites from Cistanches Herba by Human Intestinal Bacteria Using UPLC/Q-TOF-MS

An Integrated Approach to Characterize Intestinal Metabolites of Four Phenylethanoid Glycosides and Intestinal Microbe-Mediated Antioxidant Activity Evaluation in Vitro Using UHPLC-Q-Exactive High-Resolution Mass Spectrometry and a 1,1-Diphenyl-2-picrylhydrazyl-based Assay.

Microbial Biotransformation of Gentiopicroside by the Endophytic Fungus Penicillium Crustosum 2T01Y01.

Determination of Gentiopicroside and Its Excretion in Human Urine by LC/MS

The Profiling of the Metabolites of Hirsutine in Rat by Ultra-High Performance Liquid Chromatography Coupled with Linear Ion Trap Orbitrap Mass Spectrometry: an Improved Strategy for the Systematic Screening and Identification of Metabolites in Multi-Samples in Vivo

Simultaneous Determination of Eight Bioactive Compounds by LC-MS/MS and Its Application to the Pharmacokinetics, Liver First-Pass Effect, Liver and Brain Distribution of Orally Administrated Gouteng-Baitouweng (GB) in Rats.

Global analysis of qualitative and quantitative metabolism of Notoginsenoside R1 in rat liver-brain-gut axis based on LC-IT-TOF/MS combing mMDF strategy

Identification of 20(S)-Protopanaxatriol Metabolites in Rats by Ultra-Performance Liquid Chromatography Coupled with Electrospray Ionization Quadrupole Time-of-flight Tandem Mass Spectrometry and Nuclear Magnetic Resonance Spectroscopy.

The metabolism of YiGan San and subsequent pharmacokinetic evaluation of four metabolites in rat based on liquid chromatography with tandem mass spectrometry.

Evaluation of the Hepatotoxicity of the Zhi-Zi-Hou-Po Decoction by Combining UPLC-Q-Exactive-MS-Based Metabolomics and HPLC-MS/MS-Based Geniposide Tissue Distribution

Global Profiling Combined with Predicted Metabolites Screening for Discovery of Natural Compounds: Characterization of Ginsenosides in the Leaves of Panax Notoginseng As a Case Study.

Characterization of Global Metabolic Profile of Zhi-Zi-Hou-Po Decoction in Rat Bile, Urine and Feces after Oral Administration Based on a Strategy Combining LC–MS and Chemometrics

Target Profiling Analyses of Bile Acids in the Evaluation of Hepatoprotective Effect of Gentiopicroside on ANIT-induced Cholestatic Liver Injury in Mice.

Quick Identification of Xanthine Oxidase Inhibitor and Antioxidant from Erycibe Obtusifolia by a Drug Discovery Platform Composed of Multiple Mass Spectrometric Platforms and Thin-Layer Chromatography Bioautography.

Development of a Novel Sectional Multiple Filtering Scheme for Rapid Screening and Classifying Metabolites of Ziyuglycoside II in Rat Liver and Excreta Specimen Based on High-Resolution Mass Spectrometry.